Copyright © 2014 The Obesity Society
Editors: Eric Ravussin and Donna Ryan
Impact Factor: 4.389
ISI Journal Citation Reports © Ranking: 2013: 10/78 (Nutrition & Dietetics); 27/123 (Endocrinology & Metabolism)
Online ISSN: 1930-739X
Editors COI statements
Conflicts of Interest
Editors' Declared Conflicts of Interest (for the past 12 months)
Dr. David Allison has served as a consultant or independent contractor to the Federal Trade Commission (FTC), the National Institutes of Health (NIH), Arena Pharmaceuticals, Inc, Merck & Co., Inc., Pfizer Inc, VIVUS inc, American Beverage Association, Gray Consulting International Meetings & Incentives, Kraft Foods North America, McCormick Science Institute, McDonald's Corporation, Monsanto, McNeil Nutritionals, the American Federation for Medical Research, Mead-Johnson, MediFast, Scripps Genomic Medicine, The Coca-Cola Company, UNITECH Communications, Duke University Medical Center, Umass Amherst Food Science Policy Alliance, University of Arizona, University of Wisconsin - Madison, Virginia Commonwealth University.
Dr. Allison has served as a consultant and/or expert witness for Burg Simpson Eldredge Hersh and Jardin, Lightfoot Franklin White LLC, Richardson, Patrick, Westbrook & Brickman, LLC, Ulmer & Berne LLP, Williams, Kherkher, Hart and Boundas, some of whom represent dietary supplement manufacturers.
Dr. Allison has received award payments from the American Society for Nutrition.
Dr. Allison has received donations to his university from the Coca-Cola Company, Kraft Foods North America, McCormick Science Institute.
Dr. Allison has received donations to a private foundation he serves as president of from COMMUNIQUÉ, Inc., United Soybean Board, McDonald's Corporation, and Northharvest Bean Growers Association.
Dr. Allison has received grants from the National Institutes of Health (NIH), the National Science Foundation, Kraft Foods North America, McNeil Nutritionals, William Wrigley, Jr. Company, Frito-Lay North America.
Dr. Allison receives royalties as editor for the Sage Publications Inc. book: Handbook of Assessment Methods for Eating Behaviors and Weight-Related Problems.
Caroline M. Apovian
Dr. Apovian serves as a consultant for Novo-Nordisk, Arena Pharmaceuticals, Merck Pharmaceuticals, Amylin Pharmaceuticals, GI Dynamics, Johnson & Johnson Inc, Sanofi Aventis Groupe, Orexigen Pharmaceuticals, and Pfizer. Dr. Apovian, as an investigator, receives research support from Amylin Pharmaceuticals, Sanofi Aventis Groupe, Pfizer, Orexigen Therapeutics, MetaProteomics LLC, Atkins Foundation, and Arena Pharmaceuticals.
Louis J. Aronne
Dr. Aronne, as an investigator, receives research support from Amylin Pharmaceuticals, Inc., Arena Pharmaceuticals, Inc., F. Hoffmann- La Roche, Ltd., Novo Nordisk, Orexigen Therapeutics, Inc., Pfizer Inc., TransTech Pharma, Inc., Schering-Plough, Merck, VIVUS, and Sanofi-Aventis.
Dr. Aronne is a Scientific Advisor for Amylin Pharmaceuticals, Inc., GI Dynamics, Inc., Johnson & Johnson, Merck & Co., NeuroSearch, Inc., Novo Nordisk, Orexigen Therapeutics, Inc., Pfizer Inc., Sanofi-aventis, and Vivus, Inc.
Dr. Aronne has ownership interest in CardioMetabolic Support Network, LLC
Dr. Bogardus declares no conflict of interest.
Kevin P. Davy
Dr. Davy, as an investigator, receives research support from Pfizer Global Pharmaceuticals.
Dr. Dunaif serves as a consultant for Bristol-Myers Squibb Company.
Dr. Dunaif has equities in Merck and Company, Inc., Amgen, Inc., and Proctor and Gamble Company.
Cara B. Ebbeling
Dr. Ebbeling receives research support from the New Balance Foundation (a non-profit affiliated with the New Balance corporation).
Dr. Fabbrini declares no conflict of interest.
Steven B. Heymsfield
Dr. Heymsfield declares no conflict of interest.
Ronald M. Krauss
Dr. Krauss serves on the Advisory Board for Isis Pharmaceuticals, Merck, Merck Schering Plough, and Bay City Capital.
Dr. Krauss serves as a consultant for ActivX Biosciences, Celera, Corcept Therapeutics, Metabolex.
Dr. Krauss receives research support from ActivX Biosciences.
Dr. Krauss is on the Speakers Bureaus for Merck, and Merck/Schering-Plough.
David S. Ludwig
Dr. Ludwig receives support from the New Balance Foundation (a non-profit affiliated with the New Balance corporation) for research, patient care and community work.
Steven D. Mittelman
Dr. Mittelman declares no conflict of interest.
Christopher P. O'Donnell
Dr. O'Donnell declares no conflict of interest.
Dr. Poirier declares no conflict of interest.
Dr. Reitman declares no conflict of interest.
Vanessa H. Routh
Dr. Routh declares no conflict of interest.
Jacqueline M. Stephens
Dr. Stephens declares no conflict of interest.
Richard S. Surwit
Dr. Surwit serves as a consultant for Inverness Medical Innovations. Additionally, his spouse is an employee. However, it is independent of his work at Duke, including his research in the area of obesity and diabetes. Dr. Surwit has received funding from Shire pharmaceuticals and been a paid consultant to Vivus.
Dr. Wadden serves on the Advisory Board for Novo Nordisk, and Orexigen Therapeutics, Inc.
Dr. Wadden is a consultant for ClinSmart, GlaxoSmithKline, Merck, Vivus, and Wyeth.
Dr. Wadden also has received research support from Novo Nordisk and Orexigen Pharmaceuticals.
Richard M. Watanabe
Dr. Watanabe receives research support and honoraria from Merck & Co.
Dr. Watanabe receives non-financial material support from Takeda Pharmaceuticals North America.
Dr. West serves on the advisory board of Jenny Craig, Inc.